CORC  > 华南理工大学
Altered Metabolism and Metabolism-Mediated Drug-Drug Interaction of Arbidol in Patients with Liver Cancer
Zhang, Shu-Yao[1]; Zhang, Sheng-Qi[2]; Xi, Bao-Shan[3]; Lin, Li-Fang[1]; Qiu, Guo-Dong[1]; Zheng, Jie-Ting[1]; Zheng, Yu-Qiong[3]
刊名LATIN AMERICAN JOURNAL OF PHARMACY
2016
卷号35页码:1469-1472
关键词arbidol liver cancers metabolism metabolism-based drug-drug interaction
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2193646
专题华南理工大学
作者单位1.[1]Shantou Univ, Dept Pharm, Coll Med, Canc Hosp, Shantou, Guangdong, Peoples R China
2.[2]Shantou Univ, Lymphat Dept Internal Med, Coll Med, Canc Hosp, Shantou, Guangdong, Peoples R China
3.[3]Shantou Univ, Clin Lab, Coll Med, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Shu-Yao[1],Zhang, Sheng-Qi[2],Xi, Bao-Shan[3],et al. Altered Metabolism and Metabolism-Mediated Drug-Drug Interaction of Arbidol in Patients with Liver Cancer[J]. LATIN AMERICAN JOURNAL OF PHARMACY,2016,35:1469-1472.
APA Zhang, Shu-Yao[1].,Zhang, Sheng-Qi[2].,Xi, Bao-Shan[3].,Lin, Li-Fang[1].,Qiu, Guo-Dong[1].,...&Zheng, Yu-Qiong[3].(2016).Altered Metabolism and Metabolism-Mediated Drug-Drug Interaction of Arbidol in Patients with Liver Cancer.LATIN AMERICAN JOURNAL OF PHARMACY,35,1469-1472.
MLA Zhang, Shu-Yao[1],et al."Altered Metabolism and Metabolism-Mediated Drug-Drug Interaction of Arbidol in Patients with Liver Cancer".LATIN AMERICAN JOURNAL OF PHARMACY 35(2016):1469-1472.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace